Ir a las Transacciones
Private Equity | Salud

Eterus Capital has partnered with Dr. Martin to expand its dental clinic network

Dr. Martin Dental Clinic, a leading network of dental clinics in Slovakia, has received a significant investment from Eterus Capital and Ethernum Capital to support its expansion across the country. The group aims to become Slovakia’s largest dental care provider through a "buy-and-build" strategy, combining new clinic openings with acquisitions.

Eterus Capital is a private equity fund founded in 2008, specializing in supporting small and medium-sized enterprises with proven business models and growth potential. The fund focuses on minority investments, ensuring management control remains with the original shareholders. Over the years, Eterus Capital has provided more than US$41 million (€40 million) in funding to over 20 companies. Its portfolio includes prominent brands such as Sygic, HOPIN, eyerim, Saneca Pharmaceuticals, Groupsolver and MTBIKER.

Dr. Martin is a leading private dental care group in Slovakia, with over a decade of experience offering comprehensive services such as implantology, prosthetics and other restorative and aesthetic dental treatments. The group currently operates four modern dental clinics and a pediatric clinic under the Dr. Martinko brand, employing approximately 130 professionals.

Oaklins’ team in Slovakia advised Eterus Capital on this transaction.

Partes

Contáctese con el equipo de la transacción

Boris Kostik

Socio
Bratislava, Eslovaquia
Oaklins WOOD & Co.

Emma Jávorka

Asociado Senior
Bratislava, Eslovaquia
Oaklins WOOD & Co.

Transacciones relacionadas

Medicija has acquired Saulės Šeimos Medicinos Centras
Salud

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Aprenda más
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Salud

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Aprenda más
IXICO has completed a fundraising
Salud

IXICO has completed a fundraising

IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.

Aprenda más